IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.

por Luis M Real, Karin Neukam, Rocío Herrero, Josep M Guardiola, Thomas Reiberger, Antonio Rivero-Juarez, Juliana Salazar, Mattias Mandorfer, Dolores Merino, Vicente Soriano, Antonio Rivero, Juan Macías, Juan A Pineda, Antonio Caruz
Publicado 2014

<i>CD46</i> Genetic Variability and HIV-1 Infection Susceptibility

por Carmen Serrano-Rísquez, Mohamed Omar, María Amparo Gómez-Vidal, Luis Miguel Real, Juan Antonio Pineda, Antonio Rivero, Antonio Rivero-Juárez, Donald Forthal, Francisco J. Márquez, Sergio Lo Caputo, Mario Clerici, Mara Biasin, Antonio Caruz
Publicado 2021

Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

por Antonio Rivero-Juárez, Angela Camacho, Nicolás Merchante, Inés Pérez-Camacho, Juan Macias, Carmen Ortiz-Garcia, Celia Cifuentes, Julián Torre-Cisneros, José Peña, Juan A Pineda, Antonio Rivero, Grupo para el estudio de las hepatitis vı´ricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI)
Publicado 2013

Safety and efficacy of autologous non-hematopoietic enriched stem cell nebulization in COVID-19 patients: a randomized clinical trial, Abu Dhabi 2020

por Yendry Ventura-Carmenate, Fatima Mohammed Alkaabi, Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Yasmine Maher Ahmed, Pierdanilo Sanna, Ayesha Abdulla Almarzooqi, Abeer Abdelrazik, Gina Marcela Torres-Zambrano, Maura Wade-Mateo, David Quesada-Saliba, Loubna Abdel Hadi, Antonio Alfonso Bencomo-Hernandez, Rene Antonio Rivero-Jimenez
Publicado 2021